Literature DB >> 18405389

Low prevalence of Chlamydia trachomatis infection in asymptomatic young Swiss men.

David Baud1, Katia Jaton, Claire Bertelli, Jean-Pierre Kulling, Gilbert Greub.   

Abstract

BACKGROUND: Prevalence and risk factors for Chlamydia trachomatis infection among young men in Switzerland is still unknown. The objective of the present study was to assess prevalence and risk factors for C. trachomatis infection in young Swiss men.
METHODS: 517 young Swiss men were enrolled in this cross-sectional study during their compulsory military recruitment. Participants completed a questionnaire and gave urine samples which were screened for C. trachomatis DNA by PCR. Genotyping of positive samples was done by amplification and sequencing the ompA gene.
RESULTS: The prevalence of chlamydial infection among young Swiss male was 1.2% (95% confidence interval [95%CI], 0.4-2.5%). C. trachomatis infection was only identified among the 306 men having multiple sexual partner. Although frequent, neither unprotected sex (absence of condom use), nor alcohol and drug abuse were associated with chlamydial infection. Men living in cities were more frequently infected (2.9%, 95%CI 0.8-7.4%) than men living in rural areas (0.5%, 95%CI 0.1-1.9%, p = 0.046). Moreover, naturalised Swiss citizens were more often positive (4.9%, 95%CI 1.3-12.5%) than native-born Swiss men (0.5%, 95%CI 0.1-1.7%, p = 0.003).
CONCLUSION: In comparison with other countries, the prevalence of chlamydial infection in men is extremely low in Switzerland, despite a significant prevalence of risky sexual behaviour. C. trachomatis infection was especially prevalent in men with multiple sexual partners. Further research is required (i) to define which subgroup of the general population should be routinely screened, and (ii) to test whether such a targeted screening strategy will be effective to reduce the prevalence of chlamydial infection among this population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18405389      PMCID: PMC2359751          DOI: 10.1186/1471-2334-8-45

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Chlamydia trachomatis infection is the commonest sexually transmitted bacterial disease in European countries [1,2] and in the United States [3,4]. Although the major impact of disease is on the female genital tract [1,2], men may suffer from urethritis, prostatitis, infertility and Reiter's syndrome [1]. The most frequent risk factors associated with chlamydial infection are related to sexual behaviour, i.e. early age of first intercourse, multiple partners, and inconsistent condom use [1]. Since most infections caused by C. trachomatis are asymptomatic, the establishment of screening programs, as already done in some developed countries, is necessary to control the disease [5]. The studies carried out in Europe on C. trachomatis infection among young males have shown high rates ranging from 7.8–13.3%[1,6-11]. Similar prevalence were observed in other developed (3.7–5.3% [4,12-14]) and developing countries (3.1–7.9% [15,16]). However, no data are available from Switzerland. The present cross-sectional study is intended to determine the prevalence of and risk factors for C. trachomatis infection among young healthy Swiss males.

Methods

In this study approved by the ethical committee of the University of Lausanne (n° 177/06), we included all 18–26 years-old Swiss men who presented for their medical entry examination at the Army Recruitment Centre of Lausanne, Switzerland during winter 2006–2007 and who gave written consent for urinary C. trachomatis screening. The volunteers completed a questionnaire on sociodemographic, sexual and behavioral risk factors. Our questionnaire was adapted from questionnaires used in previous published studies measuring sexually transmitted infections [6,12,17-19]. Completion of the questionnaire was accurately done, since answers to similar and complementary questions formulated in different ways were 97% and 95% congruent for demographic questions and for questions on their sexual activities, respectively. DNA was extracted from centrifuged first-void urine and analyzed by real-time Taqman PCR, as described [20]. This PCR exhibited an excellent analytical sensitivity of 1 copy per reaction, good intrarun and interrun reliability, and a specificity of 100% when considering Cobas Amplicor as gold standard [20]. Positive samples were then genotyped using ompA sequencing [21]. Statistical analyses were performed using STATA (College-Station, USA). Confidence Intervals were calculated using the Daly method [22].

Results

Among 521 eligible men, four did not complete the questionnaire and were excluded. The sociodemographic characteristics of the 517 remaining volunteers are shown in Table 1. The mean age was 20.6 years (standard deviation ± 1.4 years). A total of 87% of the participants reported being sexually-experienced and 59.9% of the participants reported having more than two sexual partners in their life span. The consistent use of condoms for all sexual relations was reported by 32.3% of the 517 volunteers. Among those with more than 4 partners (n = 178), 21.3% regularly used condoms. While 67.9% of the study participants drank alcohol at least every week-end, 3.5% drank alcohol every day. Almost half (47.6%) of the participants were cigarette smokers, and 28.1% of them smoke more than 20 cigarettes per day. Occasional or daily cannabis consumption was reported by 27.1% and 7.8% of the participants, respectively. Ecstasy, heroin or cocaine have been taken by 6.4% of the studied population.
Table 1

Chlamydia trachomatis prevalence according to various demographic and behavioural variables

CharacteristicsC. trachomatis negative(%)C. trachomatis positive(%)p-value*Odds Ratio95% CIPrevalence of C. trachomatisDaly 95% CI
Total51198.861.21.20,4 – 2,5
Age (year ± SD)20.6 + 1.420.7 + 2.7
 ≤ 2027654583.30.23ref1.80.6 – 4.2
 > 2023546116.70.230,03 – 2,020.40 – 2.4
Nationality at birth
 Switzerland43384.7233.30.003ref0.50.1 – 1.7
 Europe418116.75.30,47 – 59,52.40.1 – 13.3
 Other377.235017.62,84 – 1087.51.5 – 21.9
Place of residence
 > 10'000 inhabitants13426.2466.70.046ref2.90.8 – 7.4
 < 10'000 inhabitants37773.8233.30.170.03 – 0.980.50.1 – 1.9
Main occupation
 Work26551.9466.70.74ref1.50.4 – 3.8
 Studies23145.2233.30.530,1 – 2,690.90.1 – 3.1
 Declined to respond152.900--00 – 20
Monthly income
 < 1000 Frs.30158.9116.70.064ref0.30 – 1.8
 1000 – 2000 Frs.6913.5116.74.40,3 – 70,61.40 – 8
 > 2000 Frs.11221.9466.710.81,2 – 97,23.50.9 – 8.8
 Declined to respond295.700--00 – 10,3

Number of lifetime sexual partner
 06713.1000.26--00 – 4.5
 112524.500--00 – 2,4
 ≥ 230659.96100--1.90.7 – 4.2
 Declined to respond132.500--00 – 23
Sexual orientation
 heterosexual38675.5466.70.66ref10.3 – 2.6
 homo/bisexual91.800--00 – 33,3
 Declined to respond11622.7233.31.70,3 – 9,21.70.2 – 6.1
Condom use
 Always16532.3233.31ref1.20.1 – 4.3
 Sometimes23846.63501.040,17 – 6,291.20.3 – 3.6
 Never7414.5116.71.110,10 – 12,51.30 – 7.4
 Declined to respond346.700--00 – 8.8

* Fisher's exact chi2

Chlamydia trachomatis prevalence according to various demographic and behavioural variables * Fisher's exact chi2 The prevalence of chlamydial infection was 1.2% (95%CI 0.4–2.5%) among all 517 volunteers and of 1.3% (95%CI 0.3–2.4%) among the 450 sexually-experienced men. No participants without or with only a single lifetime sexual partner were diagnosed with chlamydial infection. Conversely, 1.9% (95%CI 0.7–4.2%) of those with multiple sexual partners were C. trachomatis positive. Two men who tested positive for Chlamydia reported having consistently used condoms during all sexual relations. Among the 9 men who reported having had a male sexual partner, none had a positive Chlamydia test. When considering only Swiss born men, the prevalence was 0.5% (95%CI 0.2–2.1%). Conversely, among foreign born naturalized men who originated from Europe, the prevalence was 2.4% (95CI 0.1–13.3%). For those originated from foreign countries outside Europe, a prevalence of 7.5% (95%CI 1.5–21.9%) was observed. Young men living in cities more than 10'000 inhabitants and/or earning more than 2000 SFrs (1600 US$) were at increased risk of C. trachomatis infection (Table 1). Alcohol, cigarette, cannabis and illegal drug consumption were frequently recorded, but were not associated with chlamydial infection. Chlamydial serotypes were E (n = 3), J, Ia and D (n = 1 each).

Discussion

Our cross-sectional study provides, for the first time, prevalence data of C. trachomatis infection in young Swiss men. In Switzerland, previous studies mainly focused on women and evaluated highly selected study populations [23]. A 2.8% prevalence was recorded among asymptomatic sexually active Swiss women in 1998 [23]. However, studied women were mainly from urban area, where the prevalence is higher. Moreover, age of first sexual intercourse is lower for women or occur with older partner [24], likely also contributing to increased prevalence in women. C. trachomatis is a reportable disease in Switzerland. Since 1999, there has been a significant increase (64%) in the number of official reports of C. trachomatis infection in Switzerland [25,26]. However, among the 517 asymptomatic young Swiss men we investigated, the prevalence was only 1.2%. This Chlamydia prevalence is much lower than that reported for young asymptomatic males in Norway (7.8%)[6], Scotland (9.8%) [8] and the entire UK (13.3%) [1]. In USA, prevalence is also higher than that found in Switzerland, ranging from 3.7% [4] to 5.3% [13]. Multiple partners and inconsistent condom use are recognised as important predictors of C. trachomatis infection [1,6,16]. However, screening on the basis of condom use would have missed a substantial number of infections in the population we studied, since two of six infected men reported having always used condoms. The effect or no effect of condom use as a preventive mesure should ideally be confirmed in a larger cohort. In our study, variables associated with C. trachomatis infection were "multiple sexual partners", "living in a large city" and "foreign born, naturalized". The higher prevalence observed in the latter subgroup, similar to that of other European and non-European countries, demonstrate that the overall low prevalence of 1.2% we observed was not due to a low sensitivity of the PCR, but rather reflects a true local difference in prevalence. Serotype E was more prevalent in Switzerland, as it is the case in other European countries [21,27].

Conclusion

This is the first study of the prevalence of C. trachomatis infection conducted in young Swiss males. Since military service is compulsory for all Swiss men, the study population we screened corresponds to an unselected and unbiased representative sample of young healthy Swiss men. Despite a prevalence of sexual risk behaviour which is similar to that recorded in other countries [24], C. trachomatis prevalence in Swiss males is extremely low. In the future, in order to identify populations with a high prevalence that may benefit from mass screening, it will be important to more precisely identify risks factors associated with chlamydial infection.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

DB and GG initiated and designed the study, interpreted the results. DB, CB and GG performed the statistical analyses. DB and JPK were responsible for patient recruitment, clinical assessment, data management and blood sampling. KJ and GG did the laboratory analyses. The paper was written by DB and GG, and reviewed by all other contributors.

Pre-publication history

The pre-publication history for this paper can be accessed here:
  27 in total

1.  The molecular epidemiology of genital Chlamydia trachomatis in the greater Reykjavik area, Iceland.

Authors:  Kristín Jónsdóttir; Már Kristjánsson; Jón Hjaltalín Olafsson; Olafur Steingrímsson
Journal:  Sex Transm Dis       Date:  2003-03       Impact factor: 2.830

2.  National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland.

Authors:  W John Paget; Reinhard Zbinden; Eva Ritzler; Marcel Zwahlen; Christian Lengeler; Dieter Stürchler; Hans C Matter
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

3.  Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection.

Authors:  K A Fenton; C Korovessis; A M Johnson; A McCadden; S McManus; K Wellings; C H Mercer; C Carder; A J Copas; K Nanchahal; W Macdowall; G Ridgway; J Field; B Erens
Journal:  Lancet       Date:  2001-12-01       Impact factor: 79.321

4.  Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits.

Authors:  J A Cecil; M R Howell; J J Tawes; J C Gaydos; K T McKee; T C Quinn; C A Gaydos
Journal:  J Infect Dis       Date:  2001-09-27       Impact factor: 5.226

5.  Prevalence of STD and HIV infections among attenders of the Erasmus MC STD clinic, Rotterdam, The Netherlands, during the years 1996 to 2000.

Authors:  E M van der Snoek; H M Götz; P G H Mulder; R P Verkooyen; W I van der Meijden
Journal:  Int J STD AIDS       Date:  2003-02       Impact factor: 1.359

6.  Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County.

Authors:  Maria Lysén; Anders Osterlund; Carl-Johan Rubin; Tina Persson; Ingrid Persson; Björn Herrmann
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Genital Chlamydia trachomatis infection in a subgroup of young men in the UK.

Authors:  Louise McKay; Hilary Clery; Katy Carrick-Anderson; Sarah Hollis; Gordon Scott
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

8.  Prevalence of chlamydial and gonococcal infections among young adults in the United States.

Authors:  William C Miller; Carol A Ford; Martina Morris; Mark S Handcock; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen Mullan Harris; J Richard Udry
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

9.  Population-based outreach for Chlamydia screening in men: results from a randomized trial.

Authors:  Delia Scholes; Fred E Heidrich; Patricia Yarbro; Jeff E Lindenbaum; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

10.  Feasibility and short-term impact of linked education and urine screening interventions for Chlamydia and gonorrhea in male army recruits.

Authors:  Christine M Arcari; Joel C Gaydos; M Renee Howell; Kelly T McKee; Charlotte A Gaydos
Journal:  Sex Transm Dis       Date:  2004-07       Impact factor: 2.830

View more
  13 in total

Review 1.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

2.  Prevalence and associated factors for Chlamydia trachomatis infection among undocumented immigrants in a primary care facility in Geneva, Switzerland: a cross-sectional study.

Authors:  Yves Jackson; Paul Sebo; Gaelle Aeby; Patrick Bovier; Beatrice Ninet; Jacques Schrenzel; Philippe Sudre; Dagmar Haller; Jean-Michel Gaspoz; Hans Wolff
Journal:  J Immigr Minor Health       Date:  2010-12

3.  Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies.

Authors:  D Baud; L Regan; G Greub
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-28       Impact factor: 3.267

4.  Sexual and reproductive health behaviors of undocumented migrants in Geneva: a cross sectional study.

Authors:  Paul Sebo; Yves Jackson; Dagmar M Haller; Jean-Michel Gaspoz; Hans Wolff
Journal:  J Immigr Minor Health       Date:  2011-06

5.  Development of a new chlamydiales-specific real-time PCR and its application to respiratory clinical samples.

Authors:  Julia Lienard; Antony Croxatto; Sebastien Aeby; Katia Jaton; Klara Posfay-Barbe; Alain Gervaix; Gilbert Greub
Journal:  J Clin Microbiol       Date:  2011-05-11       Impact factor: 5.948

6.  Diagnostic relevance of simultaneous testing for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  B Sakem; R Michel; U E Nydegger; D Radjenovic; M Wydler; M Risch; L Risch
Journal:  Infection       Date:  2011-04-27       Impact factor: 3.553

7.  Role of Waddlia chondrophila placental infection in miscarriage.

Authors:  David Baud; Geneviève Goy; Maria-Chiara Osterheld; Antony Croxatto; Nicole Borel; Yvan Vial; Andreas Pospischil; Gilbert Greub
Journal:  Emerg Infect Dis       Date:  2014-03       Impact factor: 6.883

8.  Chlamydia trachomatis prevalence, genotype distribution and identification of the new Swedish variant in Southern Germany.

Authors:  N Fieser; U Simnacher; Y Tausch; S Werner-Belak; S Ladenburger-Strauss; H von Baum; U Reischl; A Essig
Journal:  Infection       Date:  2012-08-02       Impact factor: 3.553

9.  A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of labbafinejad hospital, tehran, iran.

Authors:  Omid Yeganeh; Mahmood Jeddi-Tehrani; Farhad Yaghmaie; Kourosh Kamali; Hamed Heidari-Vala; Hojjat Zeraati; Nasser Shakhssalim; Saeed Zarei; Leili Chamani-Tabriz
Journal:  Iran Red Crescent Med J       Date:  2013-04-05       Impact factor: 0.611

10.  Testing for Chlamydia trachomatis: time trends in positivity rates in the canton of Basel-Stadt, Switzerland.

Authors:  C Schmutz; D Burki; R Frei; M Mäusezahl-Feuz; D Mäusezahl
Journal:  Epidemiol Infect       Date:  2012-11-19       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.